SAB Biotherapeutics (SABS) Stock Chart & Stock Price History $1.70 +0.05 (+2.72%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SAB Biotherapeutics Stock Price Performance 5 Day Performance-2.86%1 Month Performance+41.67%3 Month Performance-22.37%6 Month Performance-56.19%Year-To-Date Performance-55.15%1 Year Performance-58.94% Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SABS Stock Chart for Thursday, May, 1, 2025 SABS Chart by TradingView SAB Biotherapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2025$1.66$1.70+2.72%$1.78$1.5817,633 shs$15.79 million04/29/2025$1.77$1.66-6.23%$1.78$1.6411,598 shs$15.37 million04/28/2025$1.75$1.77+0.86%$1.81$1.6432,743 shs$16.40 million04/25/2025$1.50$1.75+16.67%$1.75$1.4443,951 shs$16.26 million04/24/2025$1.37$1.50+9.49%$1.50$1.348,093 shs$13.93 million04/23/2025$1.30$1.37+5.38%$1.40$1.3015,427 shs$12.73 million04/22/2025$1.43$1.30-8.83%$1.45$1.3037,066 shs$12.08 million04/21/2025$1.43$1.43-0.56%$1.49$1.3353,700 shs$13.25 million04/18/2025$1.43$1.43$1.44$1.39869 shs$13.32 million04/17/2025$1.39$1.43+3.17%$1.44$1.39869 shs$13.32 million Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/16/2025$1.37$1.39+1.16%$1.48$1.3128,385 shs$12.91 million04/15/2025$1.39$1.37-1.15%$1.41$1.3114,018 shs$12.76 million04/14/2025$1.23$1.39+13.01%$1.39$1.237,658 shs$12.91 million04/11/2025$1.20$1.23+2.50%$1.23$1.1520,815 shs$11.43 million04/10/2025$1.24$1.20-2.83%$1.23$1.1414,490 shs$11.15 million04/09/2025$1.15$1.24+7.39%$1.35$1.0944,396 shs$11.47 million04/09/2025$1.15$1.24+7.39%$1.35$1.0944,396 shs$11.47 million04/08/2025$1.11$1.15+3.60%$1.17$1.0529,146 shs$10.68 million04/08/2025$1.11$1.15+3.60%$1.17$1.0529,146 shs$10.68 million04/07/2025$1.13$1.11-1.77%$1.11$1.0518,090 shs$10.31 million04/04/2025$1.18$1.13-4.24%$1.16$1.0043,834 shs$10.43 million04/03/2025$1.25$1.18-5.60%$1.30$1.1836,810 shs$10.89 million04/02/2025$1.20$1.25+4.17%$1.31$1.1521,157 shs$11.54 million04/01/2025$1.36$1.20-11.76%$1.41$1.1141,046 shs$11.08 million03/31/2025$1.48$1.36-8.11%$1.52$1.3643,736 shs$12.55 million Related Companies FBIO Stock Chart CRIS Stock Chart BOLT Stock Chart MTEM Stock Chart AMGN Stock Chart GILD Stock Chart VRTX Stock Chart REGN Stock Chart ALNY Stock Chart BIIB Stock Chart Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SABS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SABS Stock Free SABS Stock Alerts